Quarterly report pursuant to Section 13 or 15(d)

SIGNIFICANT ACCOUNTING POLICIES (Tables)

v3.10.0.1
SIGNIFICANT ACCOUNTING POLICIES (Tables)
6 Months Ended
Jun. 30, 2018
Significant Accounting Policies Tables  
Concentrations of credit risk

Revenues and accounts receivable are concentrated between two major payers with the approximate risk level outlined below.

 

Concentration of Risk
Revenue Concentration:                
      Three months ended June 30,
      2018     2017
Medicare     34.5 %     33.5 %
Commercial Payor 1     16.5 %     20.5 %
Commercial Payor 2     11.2 %     —   %
                 
      Six Months ended June 30,
      2018     2017
Medicare     35.2 %     34.0 %
Commercial Payor 1     16.2 %     19.7 %
Commercial Payor 2     10.4 %     10.0 %
                 
Receivable Concentration:                
      June 30,     June 30, 
      2018     2017
Medicare     24.0 %     34.6 %
Commercial Payor 1     10.6 %     15.5 %
Commercial Payor 2     13.4 %     12.5 %
Net (loss) income per share

Diluted net income per common share is based on the weighted-average number of common shares outstanding and potentially dilutive common shares outstanding and computed as follows:

 

    Three months ended June 30,   Six months ended June 30,
    2018   2017   2018   2017
Numerator:                
Net income (loss) attributable to First Choice Healthcare Solutions, Inc.   $ 431,549     $ (131,575 )   $ 710,887     $ 70,944  
                                 
Denominator:                                
Weighted-average common shares, basic     32,378,940       26,843,848       30,505,275       26,549,810  
Weighted-average common shares, diluted     33,178,940       26,843,848       31,305,275       27,349,810  
                                 
Basic:   $ 0.01     $ (0.00 )   $ 0.02     $ 0.00  
Diluted:   $ 0.01     $ (0.00 )   $ 0.02     $ 0.00  

 

 

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

Potentially dilutive securities excluded from the basic and diluted net income (loss) per share are as follows:

 

    Three months ended June 30,   Six months ended June 30,
    2018   2017   2018   2017
Convertible line of credit     —         800,000       —         —    
Warrants to purchase common stock     1,875,000       1,875,000       1,875,000       1,875,000  
Options to purchase common stock     3,000,000       3,000,000       3,000,000       3,000,000  
Restricted stock awards     1,201,910       660,000       1,201,910       660,000  
      6,076,910       6,335,000       6,076,910       5,535,000